

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 9.74942483 |
| 2 | drug transmembrane transport (GO:0006855) | 9.72370634 |
| 3 | lysine metabolic process (GO:0006553) | 9.28032790 |
| 4 | lysine catabolic process (GO:0006554) | 9.28032790 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.79765280 |
| 6 | organic cation transport (GO:0015695) | 8.78473433 |
| 7 | drug transport (GO:0015893) | 8.41478913 |
| 8 | phosphate ion transport (GO:0006817) | 7.51542762 |
| 9 | cysteine metabolic process (GO:0006534) | 7.05646555 |
| 10 | response to mercury ion (GO:0046689) | 6.59066275 |
| 11 | excretion (GO:0007588) | 6.55151118 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.51670135 |
| 13 | quaternary ammonium group transport (GO:0015697) | 6.41969915 |
| 14 | phosphate ion transmembrane transport (GO:0035435) | 6.37928376 |
| 15 | glyoxylate metabolic process (GO:0046487) | 6.22753659 |
| 16 | aspartate family amino acid catabolic process (GO:0009068) | 6.09141073 |
| 17 | renal absorption (GO:0070293) | 6.01329047 |
| 18 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.90758928 |
| 19 | vitamin D metabolic process (GO:0042359) | 5.73455343 |
| 20 | metanephric tubule development (GO:0072170) | 5.68510284 |
| 21 | metanephric nephron tubule development (GO:0072234) | 5.68510284 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.62221765 |
| 23 | negative regulation of cell killing (GO:0031342) | 5.62221765 |
| 24 | tricarboxylic acid metabolic process (GO:0072350) | 5.61817182 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 5.61094033 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 5.61094033 |
| 27 | tryptophan catabolic process (GO:0006569) | 5.61094033 |
| 28 | 2-oxoglutarate metabolic process (GO:0006103) | 5.54680354 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49287439 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.42617930 |
| 31 | glutathione biosynthetic process (GO:0006750) | 5.41547508 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.35461266 |
| 33 | short-chain fatty acid metabolic process (GO:0046459) | 5.28383895 |
| 34 | metanephric nephron epithelium development (GO:0072243) | 5.23046386 |
| 35 | tryptophan metabolic process (GO:0006568) | 5.21672874 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 5.19821511 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.15929056 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15634544 |
| 39 | valine metabolic process (GO:0006573) | 5.13994154 |
| 40 | branched-chain amino acid metabolic process (GO:0009081) | 5.08988717 |
| 41 | drug catabolic process (GO:0042737) | 5.05104080 |
| 42 | modified amino acid transport (GO:0072337) | 5.02337361 |
| 43 | toxin transport (GO:1901998) | 5.01635414 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.93057623 |
| 45 | kynurenine metabolic process (GO:0070189) | 4.91742697 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.86760797 |
| 47 | response to phenylpropanoid (GO:0080184) | 4.86012647 |
| 48 | carnitine transport (GO:0015879) | 4.83355694 |
| 49 | amino-acid betaine transport (GO:0015838) | 4.83355694 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 4.80580850 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.80152146 |
| 52 | metanephric epithelium development (GO:0072207) | 4.78148136 |
| 53 | cellular modified amino acid catabolic process (GO:0042219) | 4.75696899 |
| 54 | positive regulation of granulocyte differentiation (GO:0030854) | 4.69600983 |
| 55 | polyol transport (GO:0015791) | 4.64908851 |
| 56 | exogenous drug catabolic process (GO:0042738) | 4.63905982 |
| 57 | L-phenylalanine metabolic process (GO:0006558) | 4.62491473 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.62491473 |
| 59 | negative T cell selection (GO:0043383) | 4.61674830 |
| 60 | phosphate ion homeostasis (GO:0055062) | 4.58504300 |
| 61 | trivalent inorganic anion homeostasis (GO:0072506) | 4.58504300 |
| 62 | glutamate metabolic process (GO:0006536) | 4.56606194 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.53183871 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 4.50378436 |
| 65 | negative thymic T cell selection (GO:0045060) | 4.49043648 |
| 66 | fructose metabolic process (GO:0006000) | 4.48024330 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 4.47308930 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.45986710 |
| 69 | L-phenylalanine catabolic process (GO:0006559) | 4.45986710 |
| 70 | proline metabolic process (GO:0006560) | 4.40591846 |
| 71 | nephron tubule development (GO:0072080) | 4.39016265 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.37956725 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.37509245 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.36338374 |
| 75 | tolerance induction (GO:0002507) | 4.35655192 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 4.32368177 |
| 77 | peptide biosynthetic process (GO:0043043) | 4.32055902 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 4.31229827 |
| 79 | carnitine metabolic process (GO:0009437) | 4.27702425 |
| 80 | peptide catabolic process (GO:0043171) | 4.24405876 |
| 81 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.23296237 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.23296237 |
| 83 | positive T cell selection (GO:0043368) | 4.21897579 |
| 84 | positive thymic T cell selection (GO:0045059) | 4.21284376 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 4.15203925 |
| 86 | fatty acid oxidation (GO:0019395) | 4.14205529 |
| 87 | positive regulation of isotype switching (GO:0045830) | 4.12282935 |
| 88 | branched-chain amino acid catabolic process (GO:0009083) | 4.08996704 |
| 89 | vitamin transport (GO:0051180) | 4.07878335 |
| 90 | leukocyte aggregation (GO:0070486) | 4.07049177 |
| 91 | lipid oxidation (GO:0034440) | 4.06222481 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 4.05626344 |
| 93 | response to interleukin-15 (GO:0070672) | 4.04451820 |
| 94 | glycoside metabolic process (GO:0016137) | 4.01741477 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 3.96259169 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 3.92088573 |
| 97 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.91091424 |
| 98 | cellular response to interleukin-15 (GO:0071350) | 3.90321158 |
| 99 | renal tubule development (GO:0061326) | 3.89501962 |
| 100 | T cell selection (GO:0045058) | 3.86116789 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.84851580 |
| 102 | aromatic amino acid family metabolic process (GO:0009072) | 3.84251631 |
| 103 | oligosaccharide catabolic process (GO:0009313) | 3.82872349 |
| 104 | indole-containing compound metabolic process (GO:0042430) | 3.81269187 |
| 105 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.80268629 |
| 106 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.76401819 |
| 107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.76401819 |
| 108 | modulation by symbiont of host immune response (GO:0052553) | 3.76401819 |
| 109 | positive regulation by symbiont of host defense response (GO:0052509) | 3.76401819 |
| 110 | modulation by symbiont of host defense response (GO:0052031) | 3.76401819 |
| 111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.76401819 |
| 112 | NADH metabolic process (GO:0006734) | 3.74969501 |
| 113 | surfactant homeostasis (GO:0043129) | 3.73371028 |
| 114 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.73063040 |
| 115 | positive regulation of DNA recombination (GO:0045911) | 3.72867279 |
| 116 | cellular amino acid catabolic process (GO:0009063) | 3.71268763 |
| 117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.71133358 |
| 118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.70841732 |
| 119 | glutathione derivative metabolic process (GO:1901685) | 3.64621479 |
| 120 | glutathione derivative biosynthetic process (GO:1901687) | 3.64621479 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.63442945 |
| 122 | nephron epithelium development (GO:0072009) | 3.62079985 |
| 123 | alpha-amino acid catabolic process (GO:1901606) | 3.61030906 |
| 124 | thymic T cell selection (GO:0045061) | 3.60874697 |
| 125 | response to growth hormone (GO:0060416) | 3.59459238 |
| 126 | benzene-containing compound metabolic process (GO:0042537) | 3.59199186 |
| 127 | amine catabolic process (GO:0009310) | 3.57548005 |
| 128 | cellular biogenic amine catabolic process (GO:0042402) | 3.57548005 |
| 129 | transepithelial transport (GO:0070633) | 3.57388763 |
| 130 | ketone body metabolic process (GO:1902224) | 3.56919584 |
| 131 | fatty acid catabolic process (GO:0009062) | 3.53825200 |
| 132 | serine family amino acid biosynthetic process (GO:0009070) | 3.53421146 |
| 133 | cellular extravasation (GO:0045123) | 3.50690750 |
| 134 | biotin metabolic process (GO:0006768) | 3.50425468 |
| 135 | sulfur amino acid catabolic process (GO:0000098) | 3.50081153 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.49157556 |
| 137 | detection of bacterium (GO:0016045) | 3.49108099 |
| 138 | regulation of B cell differentiation (GO:0045577) | 3.48116986 |
| 139 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.47076267 |
| 140 | glutathione metabolic process (GO:0006749) | 3.46378877 |
| 141 | neutrophil activation involved in immune response (GO:0002283) | 3.45979305 |
| 142 | T cell homeostasis (GO:0043029) | 3.45202794 |
| 143 | positive regulation of B cell differentiation (GO:0045579) | 3.44340849 |
| 144 | L-ascorbic acid metabolic process (GO:0019852) | 3.43564262 |
| 145 | regulation of granulocyte differentiation (GO:0030852) | 3.39770735 |
| 146 | mast cell activation (GO:0045576) | 3.39215887 |
| 147 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.38532414 |
| 148 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.38532414 |
| 149 | T cell migration (GO:0072678) | 3.37429189 |
| 150 | defense response to protozoan (GO:0042832) | 3.37242692 |
| 151 | carboxylic acid catabolic process (GO:0046395) | 3.37146320 |
| 152 | organic acid catabolic process (GO:0016054) | 3.37146320 |
| 153 | activated T cell proliferation (GO:0050798) | 3.37005488 |
| 154 | sulfur compound transport (GO:0072348) | 3.36719814 |
| 155 | dicarboxylic acid metabolic process (GO:0043648) | 3.35786353 |
| 156 | regulation of isotype switching (GO:0045191) | 3.35552765 |
| 157 | interferon-gamma production (GO:0032609) | 3.35530675 |
| 158 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34151349 |
| 159 | sodium-independent organic anion transport (GO:0043252) | 3.33478088 |
| 160 | detection of other organism (GO:0098543) | 3.32830672 |
| 161 | leukocyte degranulation (GO:0043299) | 3.32226438 |
| 162 | oxaloacetate metabolic process (GO:0006107) | 3.30093163 |
| 163 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.29954083 |
| 164 | positive regulation of B cell mediated immunity (GO:0002714) | 3.29954083 |
| 165 | monocarboxylic acid catabolic process (GO:0072329) | 3.29352103 |
| 166 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.28957324 |
| 167 | positive regulation of immunoglobulin production (GO:0002639) | 3.28789487 |
| 168 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24759962 |
| 169 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.24346680 |
| 170 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.18590502 |
| 171 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.17162500 |
| 172 | negative regulation of phagocytosis (GO:0050765) | 3.14022904 |
| 173 | response to protozoan (GO:0001562) | 3.13960276 |
| 174 | regulation of T cell tolerance induction (GO:0002664) | 3.11733932 |
| 175 | natural killer cell differentiation (GO:0001779) | 3.10119939 |
| 176 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09976533 |
| 177 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.07624060 |
| 178 | cellular response to exogenous dsRNA (GO:0071360) | 3.07259705 |
| 179 | mast cell degranulation (GO:0043303) | 3.07082718 |
| 180 | mast cell activation involved in immune response (GO:0002279) | 3.07082718 |
| 181 | lymphocyte homeostasis (GO:0002260) | 3.05356148 |
| 182 | Peyers patch development (GO:0048541) | 3.03757866 |
| 183 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.03757866 |
| 184 | NIK/NF-kappaB signaling (GO:0038061) | 3.03266577 |
| 185 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.02931016 |
| 186 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.00437491 |
| 187 | regulation of alpha-beta T cell activation (GO:0046634) | 2.99345582 |
| 188 | negative regulation of adaptive immune response (GO:0002820) | 2.98582198 |
| 189 | myeloid cell activation involved in immune response (GO:0002275) | 2.96656010 |
| 190 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95021456 |
| 191 | germinal center formation (GO:0002467) | 2.94492138 |
| 192 | alpha-beta T cell differentiation (GO:0046632) | 2.93129105 |
| 193 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92901162 |
| 194 | B cell homeostasis (GO:0001782) | 2.92863977 |
| 195 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91620874 |
| 196 | regulation of B cell mediated immunity (GO:0002712) | 2.91576949 |
| 197 | positive regulation of B cell activation (GO:0050871) | 2.91314039 |
| 198 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.89824718 |
| 199 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.89526536 |
| 200 | macrophage activation involved in immune response (GO:0002281) | 2.88192865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.80581192 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.76414455 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.24215654 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.85045534 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.80325988 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.35712016 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.03836793 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.71083053 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70130281 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.56538234 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.44281189 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03737227 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.99959330 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.96164066 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83005601 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.76146098 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.75425067 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.70157973 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.67356246 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66761292 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66135810 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63226684 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.60258261 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.57227934 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.52148439 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48123703 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.46392831 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.43573339 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 2.43420506 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.40649987 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36299776 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.36021768 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.35985468 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34312873 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30678613 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.25334318 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24284896 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22768350 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.19728571 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18305119 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.12631968 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12009365 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.11688478 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.10907500 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09415331 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08260991 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.04690988 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 2.03460238 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98894511 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.95545733 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86736555 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83345371 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81942939 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78795053 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72526415 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71535556 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70814752 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70386326 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67360303 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66812938 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66483582 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66086655 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63053026 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61341164 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61302155 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59522615 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.58314674 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54818881 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54312300 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54153678 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51379663 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51036341 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48978290 |
| 74 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48419863 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46328117 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45388220 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44988545 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43900717 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.43135282 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40640268 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40017389 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39996334 |
| 83 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38050933 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36207913 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35488026 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33941356 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31027492 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28585878 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27036575 |
| 90 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26415900 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23611556 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23589746 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22777741 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22543918 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22467066 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21855624 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21843980 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19999643 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19831024 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19657490 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19213336 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17915930 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16425699 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16268995 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15215541 |
| 106 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14980336 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14643396 |
| 108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12604369 |
| 109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12358942 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11619455 |
| 111 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11619455 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11511403 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11100710 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10760457 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09856737 |
| 116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08699851 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08619707 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08456883 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08314037 |
| 120 | P300_27268052_Chip-Seq_Bcells_Human | 1.08224059 |
| 121 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07545610 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07427542 |
| 123 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04654967 |
| 124 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04360225 |
| 125 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03407663 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03342861 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03209372 |
| 128 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02277936 |
| 129 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01714413 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01604567 |
| 131 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.01055083 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00782490 |
| 133 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00022401 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99898162 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99239996 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98570650 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98012851 |
| 138 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97765079 |
| 139 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97757676 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97541619 |
| 141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97489329 |
| 142 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94418489 |
| 143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94031604 |
| 144 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93884122 |
| 145 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91197375 |
| 146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89989390 |
| 147 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89317478 |
| 148 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89263259 |
| 149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89038513 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88599744 |
| 151 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87917370 |
| 152 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.86915496 |
| 153 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86885753 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86077278 |
| 155 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.86066334 |
| 156 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85331329 |
| 157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84918260 |
| 158 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84288453 |
| 159 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84219764 |
| 160 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84214341 |
| 161 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83873917 |
| 162 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83355974 |
| 163 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.83317488 |
| 164 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82835491 |
| 165 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82578112 |
| 166 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.80761442 |
| 167 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80383274 |
| 168 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80186780 |
| 169 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79303987 |
| 170 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79258490 |
| 171 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.79146930 |
| 172 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79101274 |
| 173 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79009012 |
| 174 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78833669 |
| 175 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78270317 |
| 176 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77879100 |
| 177 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77008093 |
| 178 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76183410 |
| 179 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76162982 |
| 180 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.75601499 |
| 181 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75213232 |
| 182 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75029064 |
| 183 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75029064 |
| 184 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74718012 |
| 185 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.74273943 |
| 186 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74081434 |
| 187 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73912532 |
| 188 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72922903 |
| 189 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.70941143 |
| 190 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.69105441 |
| 191 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.68275956 |
| 192 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.67500146 |
| 193 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67428122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.08351855 |
| 2 | MP0004043_abnormal_pH_regulation | 6.29751551 |
| 3 | MP0005332_abnormal_amino_acid | 4.92954551 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.92950533 |
| 5 | MP0003195_calcinosis | 4.84783644 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 4.23019762 |
| 7 | MP0009643_abnormal_urine_homeostasis | 4.02452333 |
| 8 | MP0001765_abnormal_ion_homeostasis | 3.78744473 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.76603769 |
| 10 | MP0005671_abnormal_response_to | 3.74329219 |
| 11 | MP0003763_abnormal_thymus_physiology | 3.71366058 |
| 12 | MP0001835_abnormal_antigen_presentation | 3.67435408 |
| 13 | MP0003436_decreased_susceptibility_to | 3.49709145 |
| 14 | MP0001756_abnormal_urination | 3.39093313 |
| 15 | MP0001800_abnormal_humoral_immune | 3.23976054 |
| 16 | MP0000685_abnormal_immune_system | 3.09729468 |
| 17 | MP0005636_abnormal_mineral_homeostasis | 3.09007215 |
| 18 | MP0003878_abnormal_ear_physiology | 3.03441670 |
| 19 | MP0005377_hearing/vestibular/ear_phenot | 3.03441670 |
| 20 | MP0002136_abnormal_kidney_physiology | 3.01836257 |
| 21 | MP0001790_abnormal_immune_system | 3.00097228 |
| 22 | MP0005387_immune_system_phenotype | 3.00097228 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 2.93911305 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.85648761 |
| 25 | MP0004381_abnormal_hair_follicle | 2.79907220 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75171649 |
| 27 | MP0000372_irregular_coat_pigmentation | 2.65721914 |
| 28 | MP0002723_abnormal_immune_serum | 2.59738194 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.57631489 |
| 30 | MP0001819_abnormal_immune_cell | 2.53198842 |
| 31 | MP0001873_stomach_inflammation | 2.51083155 |
| 32 | MP0001958_emphysema | 2.49720866 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.45807430 |
| 34 | MP0005365_abnormal_bile_salt | 2.43673037 |
| 35 | MP0005025_abnormal_response_to | 2.35132512 |
| 36 | MP0003252_abnormal_bile_duct | 2.34327355 |
| 37 | MP0000015_abnormal_ear_pigmentation | 2.28475336 |
| 38 | MP0002419_abnormal_innate_immunity | 2.28471151 |
| 39 | MP0002398_abnormal_bone_marrow | 2.13130892 |
| 40 | MP0003303_peritoneal_inflammation | 2.08332896 |
| 41 | MP0009785_altered_susceptibility_to | 2.05388474 |
| 42 | MP0000716_abnormal_immune_system | 2.03838728 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 2.03045444 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 2.02427199 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.97440947 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.96244707 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.94607440 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.92160086 |
| 49 | MP0000538_abnormal_urinary_bladder | 1.91326093 |
| 50 | MP0005310_abnormal_salivary_gland | 1.89666714 |
| 51 | MP0002405_respiratory_system_inflammati | 1.87251790 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.85512633 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.76135996 |
| 54 | MP0002722_abnormal_immune_system | 1.75930509 |
| 55 | MP0006082_CNS_inflammation | 1.75799598 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.70262206 |
| 57 | MP0002429_abnormal_blood_cell | 1.63433579 |
| 58 | MP0003866_abnormal_defecation | 1.57473915 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.57195323 |
| 60 | MP0004885_abnormal_endolymph | 1.54840863 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.54170392 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52335502 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.52123117 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.51418246 |
| 65 | MP0005451_abnormal_body_composition | 1.50247541 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.50127473 |
| 67 | MP0004947_skin_inflammation | 1.48633707 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.47263390 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.46535658 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.43987835 |
| 71 | MP0003186_abnormal_redox_activity | 1.41951587 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.35220261 |
| 73 | MP0003283_abnormal_digestive_organ | 1.34794271 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.34557968 |
| 75 | MP0002009_preneoplasia | 1.33623355 |
| 76 | MP0002168_other_aberrant_phenotype | 1.29958948 |
| 77 | MP0000230_abnormal_systemic_arterial | 1.29460542 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.28641049 |
| 79 | MP0001851_eye_inflammation | 1.28298772 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 1.24518333 |
| 81 | MP0002132_abnormal_respiratory_system | 1.20296324 |
| 82 | MP0005670_abnormal_white_adipose | 1.16918291 |
| 83 | MP0002928_abnormal_bile_duct | 1.15073387 |
| 84 | MP0002135_abnormal_kidney_morphology | 1.14242617 |
| 85 | MP0003136_yellow_coat_color | 1.13573237 |
| 86 | MP0001666_abnormal_nutrient_absorption | 1.12964742 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 1.08160114 |
| 88 | MP0002896_abnormal_bone_mineralization | 1.07048906 |
| 89 | MP0002933_joint_inflammation | 1.05524876 |
| 90 | MP0005535_abnormal_body_temperature | 1.04281663 |
| 91 | MP0001663_abnormal_digestive_system | 1.03568458 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 1.01629726 |
| 93 | MP0002796_impaired_skin_barrier | 1.01580788 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.98618394 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.97319575 |
| 96 | MP0002089_abnormal_postnatal_growth/wei | 0.95799416 |
| 97 | MP0001764_abnormal_homeostasis | 0.94782947 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.94701749 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.93232375 |
| 100 | MP0002006_tumorigenesis | 0.92736765 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.91962693 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.91497928 |
| 103 | MP0008872_abnormal_physiological_respon | 0.86263894 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.84398662 |
| 105 | MP0001661_extended_life_span | 0.81301379 |
| 106 | MP0009278_abnormal_bone_marrow | 0.77442600 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.77093780 |
| 108 | MP0003959_abnormal_lean_body | 0.76935500 |
| 109 | MP0005171_absent_coat_pigmentation | 0.75907581 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.75804039 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.75746627 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.73634713 |
| 113 | MP0005395_other_phenotype | 0.72754932 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.72591415 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.71637209 |
| 116 | MP0003646_muscle_fatigue | 0.70849325 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.68742443 |
| 118 | MP0000490_abnormal_crypts_of | 0.68046601 |
| 119 | MP0009764_decreased_sensitivity_to | 0.67060421 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.62766691 |
| 121 | MP0005220_abnormal_exocrine_pancreas | 0.61966517 |
| 122 | MP0004147_increased_porphyrin_level | 0.60470410 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.59780425 |
| 124 | MP0005501_abnormal_skin_physiology | 0.58403773 |
| 125 | MP0003045_fibrosis | 0.58001103 |
| 126 | MP0002075_abnormal_coat/hair_pigmentati | 0.57676590 |
| 127 | MP0001324_abnormal_eye_pigmentation | 0.57346107 |
| 128 | MP0008057_abnormal_DNA_replication | 0.56571152 |
| 129 | MP0000609_abnormal_liver_physiology | 0.56289918 |
| 130 | MP0000249_abnormal_blood_vessel | 0.56251254 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.54218934 |
| 132 | MP0002098_abnormal_vibrissa_morphology | 0.54206719 |
| 133 | MP0003795_abnormal_bone_structure | 0.54195596 |
| 134 | MP0004858_abnormal_nervous_system | 0.51404299 |
| 135 | MP0008469_abnormal_protein_level | 0.50270229 |
| 136 | MP0003879_abnormal_hair_cell | 0.50160954 |
| 137 | MP0009763_increased_sensitivity_to | 0.49857352 |
| 138 | MP0009840_abnormal_foam_cell | 0.49606296 |
| 139 | MP0000534_abnormal_ureter_morphology | 0.49412412 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.48682157 |
| 141 | MP0003828_pulmonary_edema | 0.48506694 |
| 142 | MP0003315_abnormal_perineum_morphology | 0.48361931 |
| 143 | MP0000747_muscle_weakness | 0.47860636 |
| 144 | MP0004272_abnormal_basement_membrane | 0.47493523 |
| 145 | MP0005397_hematopoietic_system_phenotyp | 0.47454955 |
| 146 | MP0001545_abnormal_hematopoietic_system | 0.47454955 |
| 147 | MP0003329_amyloid_beta_deposits | 0.47288792 |
| 148 | MP0002115_abnormal_skeleton_extremities | 0.47160841 |
| 149 | MP0002078_abnormal_glucose_homeostasis | 0.46791615 |
| 150 | MP0005166_decreased_susceptibility_to | 0.46733468 |
| 151 | MP0000371_diluted_coat_color | 0.44918227 |
| 152 | MP0003953_abnormal_hormone_level | 0.43288207 |
| 153 | MP0005165_increased_susceptibility_to | 0.42824699 |
| 154 | MP0002069_abnormal_eating/drinking_beha | 0.42391851 |
| 155 | MP0000598_abnormal_liver_morphology | 0.42053090 |
| 156 | MP0005167_abnormal_blood-brain_barrier | 0.40396259 |
| 157 | MP0004742_abnormal_vestibular_system | 0.38988763 |
| 158 | MP0005375_adipose_tissue_phenotype | 0.38079552 |
| 159 | MP0003724_increased_susceptibility_to | 0.37436513 |
| 160 | MP0001485_abnormal_pinna_reflex | 0.35477648 |
| 161 | MP0000163_abnormal_cartilage_morphology | 0.35395308 |
| 162 | MP0006035_abnormal_mitochondrial_morpho | 0.35089003 |
| 163 | MP0010386_abnormal_urinary_bladder | 0.34514841 |
| 164 | MP0001177_atelectasis | 0.32073518 |
| 165 | MP0000678_abnormal_parathyroid_gland | 0.30809396 |
| 166 | MP0001270_distended_abdomen | 0.30022193 |
| 167 | MP0003075_altered_response_to | 0.29196772 |
| 168 | MP0001664_abnormal_digestion | 0.29064785 |
| 169 | MP0001963_abnormal_hearing_physiology | 0.27963972 |
| 170 | MP0000367_abnormal_coat/_hair | 0.27756476 |
| 171 | MP0009780_abnormal_chondrocyte_physiolo | 0.27706869 |
| 172 | MP0005408_hypopigmentation | 0.27669369 |
| 173 | MP0001845_abnormal_inflammatory_respons | 0.26436705 |
| 174 | MP0001731_abnormal_postnatal_growth | 0.25854078 |
| 175 | MP0004484_altered_response_of | 0.25834438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.00827118 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.82925428 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.58055244 |
| 4 | Hypomagnesemia (HP:0002917) | 7.47027313 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.15602919 |
| 6 | Polyuria (HP:0000103) | 6.90793342 |
| 7 | Gout (HP:0001997) | 6.72766151 |
| 8 | Abnormal urine output (HP:0012590) | 6.55779367 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 6.41499174 |
| 10 | Abnormality of magnesium homeostasis (HP:0004921) | 6.31810623 |
| 11 | Abnormality of renal excretion (HP:0011036) | 6.09357602 |
| 12 | Abnormal drinking behavior (HP:0030082) | 5.65424945 |
| 13 | Polydipsia (HP:0001959) | 5.65424945 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 5.43956976 |
| 15 | Tetany (HP:0001281) | 5.31680717 |
| 16 | Increased purine levels (HP:0004368) | 5.22781383 |
| 17 | Hyperuricemia (HP:0002149) | 5.22781383 |
| 18 | Proximal tubulopathy (HP:0000114) | 5.19397630 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.16076632 |
| 20 | Renal salt wasting (HP:0000127) | 5.07716561 |
| 21 | Hyperaldosteronism (HP:0000859) | 4.97778454 |
| 22 | Abnormality of renin-angiotensin system (HP:0000847) | 4.97712066 |
| 23 | Hyperglycinuria (HP:0003108) | 4.82371589 |
| 24 | Alkalosis (HP:0001948) | 4.81481006 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.73603921 |
| 26 | Stomatitis (HP:0010280) | 4.59046836 |
| 27 | T lymphocytopenia (HP:0005403) | 4.42570131 |
| 28 | Eczematoid dermatitis (HP:0000976) | 4.36090200 |
| 29 | Recurrent fungal infections (HP:0002841) | 4.35829370 |
| 30 | Abnormality of purine metabolism (HP:0004352) | 4.33170533 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.18528869 |
| 32 | Abnormality of T cell number (HP:0011839) | 4.09101998 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 4.09013134 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.09013134 |
| 35 | Abnormality of T cells (HP:0002843) | 4.04440561 |
| 36 | Hypercalciuria (HP:0002150) | 3.99479688 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88427663 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.88427663 |
| 39 | Hypokalemia (HP:0002900) | 3.83829738 |
| 40 | Ketoacidosis (HP:0001993) | 3.82381417 |
| 41 | Myositis (HP:0100614) | 3.82023180 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 3.80439498 |
| 43 | Pustule (HP:0200039) | 3.79338345 |
| 44 | Renal tubular acidosis (HP:0001947) | 3.72319948 |
| 45 | Recurrent abscess formation (HP:0002722) | 3.68130064 |
| 46 | Meningitis (HP:0001287) | 3.65794255 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.62401043 |
| 48 | IgG deficiency (HP:0004315) | 3.59401471 |
| 49 | Generalized aminoaciduria (HP:0002909) | 3.56074583 |
| 50 | Abnormality of B cell number (HP:0010975) | 3.50009682 |
| 51 | Severe combined immunodeficiency (HP:0004430) | 3.46464594 |
| 52 | Recurrent viral infections (HP:0004429) | 3.46006025 |
| 53 | Agammaglobulinemia (HP:0004432) | 3.44104865 |
| 54 | Encephalitis (HP:0002383) | 3.44075708 |
| 55 | Recurrent skin infections (HP:0001581) | 3.35980652 |
| 56 | B lymphocytopenia (HP:0010976) | 3.26493120 |
| 57 | Ketosis (HP:0001946) | 3.22454428 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 3.21608871 |
| 59 | Glycosuria (HP:0003076) | 3.21608871 |
| 60 | Inflammation of the large intestine (HP:0002037) | 3.20477127 |
| 61 | Ocular albinism (HP:0001107) | 3.17069167 |
| 62 | Abnormality of potassium homeostasis (HP:0011042) | 3.14176806 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 3.11859460 |
| 64 | Optic neuritis (HP:0100653) | 3.09105056 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 3.09105056 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08464756 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 3.01370450 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.99143292 |
| 69 | Nephrocalcinosis (HP:0000121) | 2.97971366 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 2.97934400 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.97934400 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.96508260 |
| 73 | IgM deficiency (HP:0002850) | 2.96442728 |
| 74 | Increased IgE level (HP:0003212) | 2.95827363 |
| 75 | Orchitis (HP:0100796) | 2.91420650 |
| 76 | Hypochromic anemia (HP:0001931) | 2.91227648 |
| 77 | Hyperphosphaturia (HP:0003109) | 2.91214724 |
| 78 | Vasculitis (HP:0002633) | 2.90359195 |
| 79 | Congenital stationary night blindness (HP:0007642) | 2.89293355 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.86964783 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.83937185 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.82684037 |
| 83 | Delayed CNS myelination (HP:0002188) | 2.81001603 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.80062671 |
| 85 | Delayed epiphyseal ossification (HP:0002663) | 2.80054732 |
| 86 | Lymphopenia (HP:0001888) | 2.77061946 |
| 87 | Recurrent bronchitis (HP:0002837) | 2.76765130 |
| 88 | Granulocytopenia (HP:0001913) | 2.74247348 |
| 89 | Colitis (HP:0002583) | 2.73450112 |
| 90 | Abnormal urine phosphate concentration (HP:0012599) | 2.72355057 |
| 91 | Combined immunodeficiency (HP:0005387) | 2.68612594 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.67484275 |
| 93 | Spontaneous hematomas (HP:0007420) | 2.66873707 |
| 94 | Abnormality of eosinophils (HP:0001879) | 2.66372247 |
| 95 | Nephrolithiasis (HP:0000787) | 2.65758443 |
| 96 | Leukocytosis (HP:0001974) | 2.63664476 |
| 97 | Iris hypopigmentation (HP:0007730) | 2.63555492 |
| 98 | Viral hepatitis (HP:0006562) | 2.62289921 |
| 99 | Eosinophilia (HP:0001880) | 2.62219412 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.60553278 |
| 101 | Dehydration (HP:0001944) | 2.59472566 |
| 102 | Abnormality of sodium homeostasis (HP:0010931) | 2.58923035 |
| 103 | Obstructive lung disease (HP:0006536) | 2.58119176 |
| 104 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58119176 |
| 105 | Thyroiditis (HP:0100646) | 2.56839308 |
| 106 | IgA deficiency (HP:0002720) | 2.55186471 |
| 107 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54385528 |
| 108 | Gastrointestinal stroma tumor (HP:0100723) | 2.52370799 |
| 109 | Stomach cancer (HP:0012126) | 2.48474765 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.47799316 |
| 111 | Hyperglycinemia (HP:0002154) | 2.46649552 |
| 112 | Hypophosphatemia (HP:0002148) | 2.45393493 |
| 113 | Pulmonary infiltrates (HP:0002113) | 2.44558917 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.41185955 |
| 115 | Papilloma (HP:0012740) | 2.40150577 |
| 116 | Verrucae (HP:0200043) | 2.40150577 |
| 117 | Hyponatremia (HP:0002902) | 2.39960324 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 2.39635880 |
| 119 | Widely patent fontanelles and sutures (HP:0004492) | 2.36735136 |
| 120 | Keratoconjunctivitis (HP:0001096) | 2.36093893 |
| 121 | Chest pain (HP:0100749) | 2.34728523 |
| 122 | Metaphyseal cupping (HP:0003021) | 2.32142750 |
| 123 | Rickets (HP:0002748) | 2.31227810 |
| 124 | Adrenal overactivity (HP:0002717) | 2.29871730 |
| 125 | Keratoconjunctivitis sicca (HP:0001097) | 2.28630041 |
| 126 | Vascular calcification (HP:0004934) | 2.28453763 |
| 127 | Albinism (HP:0001022) | 2.26486361 |
| 128 | Confusion (HP:0001289) | 2.25931636 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25684019 |
| 130 | Potter facies (HP:0002009) | 2.25374743 |
| 131 | Facial shape deformation (HP:0011334) | 2.25374743 |
| 132 | Dicarboxylic aciduria (HP:0003215) | 2.24381824 |
| 133 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.24381824 |
| 134 | Vomiting (HP:0002013) | 2.23433414 |
| 135 | Metabolic acidosis (HP:0001942) | 2.22933844 |
| 136 | Enlarged kidneys (HP:0000105) | 2.22223782 |
| 137 | Microcytic anemia (HP:0001935) | 2.21948822 |
| 138 | Hyperammonemia (HP:0001987) | 2.21668564 |
| 139 | Hemoptysis (HP:0002105) | 2.18841532 |
| 140 | Renal tubular dysfunction (HP:0000124) | 2.18767439 |
| 141 | Anorexia (HP:0002039) | 2.14229947 |
| 142 | Malnutrition (HP:0004395) | 2.12438852 |
| 143 | Abnormality of the fingertips (HP:0001211) | 2.10630530 |
| 144 | Cellulitis (HP:0100658) | 2.10519490 |
| 145 | Tubular atrophy (HP:0000092) | 2.06904213 |
| 146 | Basal cell carcinoma (HP:0002671) | 2.06819269 |
| 147 | Chronic otitis media (HP:0000389) | 2.06292348 |
| 148 | Epistaxis (HP:0000421) | 2.05219628 |
| 149 | Lymphoma (HP:0002665) | 2.03785167 |
| 150 | Gingivitis (HP:0000230) | 2.03385717 |
| 151 | Cardiovascular calcification (HP:0011915) | 2.02726573 |
| 152 | Urticaria (HP:0001025) | 2.02673402 |
| 153 | Chronic diarrhea (HP:0002028) | 2.01994383 |
| 154 | Chondrocalcinosis (HP:0000934) | 2.01070162 |
| 155 | Autoimmune thrombocytopenia (HP:0001973) | 1.99154950 |
| 156 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98410877 |
| 157 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.98232474 |
| 158 | Abnormality of renal resorption (HP:0011038) | 1.98012352 |
| 159 | Tubulointerstitial fibrosis (HP:0005576) | 1.97424795 |
| 160 | Increased IgM level (HP:0003496) | 1.97244387 |
| 161 | Decreased circulating renin level (HP:0003351) | 1.97200147 |
| 162 | Abnormality of the prostate (HP:0008775) | 1.94684715 |
| 163 | Recurrent pneumonia (HP:0006532) | 1.94009676 |
| 164 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.92802480 |
| 165 | Abnormal tarsal ossification (HP:0008369) | 1.92611448 |
| 166 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.92208938 |
| 167 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.91366119 |
| 168 | Sepsis (HP:0100806) | 1.89216200 |
| 169 | Abnormality of Sharpey fibers (HP:0100685) | 1.88876036 |
| 170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86462360 |
| 171 | Lethargy (HP:0001254) | 1.86345388 |
| 172 | Osteomyelitis (HP:0002754) | 1.85323079 |
| 173 | Methylmalonic aciduria (HP:0012120) | 1.83779159 |
| 174 | Hypotension (HP:0002615) | 1.83635007 |
| 175 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81666412 |
| 176 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81337045 |
| 177 | Bicornuate uterus (HP:0000813) | 1.79299897 |
| 178 | Thin bony cortex (HP:0002753) | 1.78980038 |
| 179 | Nausea (HP:0002018) | 1.69166001 |
| 180 | Irritability (HP:0000737) | 1.65353446 |
| 181 | Generalized muscle weakness (HP:0003324) | 1.65075693 |
| 182 | Abnormality of the costochondral junction (HP:0000919) | 1.64906820 |
| 183 | Metaphyseal irregularity (HP:0003025) | 1.64423780 |
| 184 | Lymphangioma (HP:0100764) | 1.63396331 |
| 185 | Abnormality of carpal bone ossification (HP:0006257) | 1.60395861 |
| 186 | Glomerulosclerosis (HP:0000096) | 1.60041363 |
| 187 | Neonatal onset (HP:0003623) | 1.58507009 |
| 188 | Abnormal eating behavior (HP:0100738) | 1.54977183 |
| 189 | Tachypnea (HP:0002789) | 1.53197333 |
| 190 | Axonal loss (HP:0003447) | 1.51084039 |
| 191 | Metaphyseal dysplasia (HP:0100255) | 1.46266441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 9.41962738 |
| 2 | WNK4 | 7.98260985 |
| 3 | OXSR1 | 7.67493251 |
| 4 | ITK | 6.85677917 |
| 5 | RIPK4 | 3.98160316 |
| 6 | STK39 | 3.83085930 |
| 7 | TXK | 3.21469559 |
| 8 | MAP4K2 | 2.96889374 |
| 9 | BLK | 2.71474149 |
| 10 | BCKDK | 2.64889825 |
| 11 | TNK2 | 2.35479033 |
| 12 | STK38L | 2.31969500 |
| 13 | BTK | 2.26536906 |
| 14 | CDK12 | 2.19057112 |
| 15 | FES | 2.15446078 |
| 16 | SYK | 2.08818078 |
| 17 | IRAK4 | 2.07645706 |
| 18 | TAOK3 | 1.99953011 |
| 19 | PDK2 | 1.98282316 |
| 20 | PDK4 | 1.87700121 |
| 21 | PDK3 | 1.87700121 |
| 22 | ZAP70 | 1.87109368 |
| 23 | SGK494 | 1.86834213 |
| 24 | SGK223 | 1.86834213 |
| 25 | TLK1 | 1.86221556 |
| 26 | MARK3 | 1.80088248 |
| 27 | NEK1 | 1.74636626 |
| 28 | MAP3K10 | 1.66881484 |
| 29 | WNK1 | 1.62997673 |
| 30 | BRD4 | 1.59987152 |
| 31 | HCK | 1.53698949 |
| 32 | TEC | 1.52126596 |
| 33 | IKBKE | 1.51665914 |
| 34 | MST1R | 1.49420982 |
| 35 | LCK | 1.43412732 |
| 36 | LYN | 1.41938779 |
| 37 | MST4 | 1.37394375 |
| 38 | JAK3 | 1.36314403 |
| 39 | KIT | 1.35703424 |
| 40 | IKBKB | 1.33118252 |
| 41 | CAMKK2 | 1.32570207 |
| 42 | ACVR1B | 1.30638981 |
| 43 | NLK | 1.22406592 |
| 44 | STK38 | 1.19538473 |
| 45 | TBK1 | 1.16401900 |
| 46 | CAMKK1 | 1.09710597 |
| 47 | TESK2 | 1.07691891 |
| 48 | SGK2 | 1.06586696 |
| 49 | FGFR4 | 1.06526747 |
| 50 | SIK2 | 1.05924902 |
| 51 | SGK3 | 1.01697013 |
| 52 | PRPF4B | 0.99989196 |
| 53 | MAPK7 | 0.99691106 |
| 54 | LRRK2 | 0.96517517 |
| 55 | JAK1 | 0.95642272 |
| 56 | CSF1R | 0.93953395 |
| 57 | PINK1 | 0.93026461 |
| 58 | FGFR3 | 0.89206705 |
| 59 | PASK | 0.83378059 |
| 60 | ERN1 | 0.82210187 |
| 61 | HIPK2 | 0.81256608 |
| 62 | EPHB1 | 0.74239486 |
| 63 | GSK3A | 0.73705352 |
| 64 | MAP3K3 | 0.70096636 |
| 65 | SMG1 | 0.69101983 |
| 66 | PIK3CG | 0.68314333 |
| 67 | CHUK | 0.67843946 |
| 68 | TGFBR2 | 0.67572829 |
| 69 | CDK4 | 0.67012888 |
| 70 | GRK6 | 0.66371760 |
| 71 | TIE1 | 0.63025023 |
| 72 | CDC42BPA | 0.62969052 |
| 73 | MAP3K1 | 0.61958450 |
| 74 | FGR | 0.60642561 |
| 75 | MELK | 0.58671837 |
| 76 | MAP3K7 | 0.58593089 |
| 77 | SGK1 | 0.57339265 |
| 78 | MARK2 | 0.55197862 |
| 79 | TAOK1 | 0.54716396 |
| 80 | DYRK1B | 0.54568201 |
| 81 | INSRR | 0.52888264 |
| 82 | BMPR2 | 0.50792187 |
| 83 | PTK2 | 0.50371623 |
| 84 | PRKAA1 | 0.50250993 |
| 85 | SIK3 | 0.50069571 |
| 86 | MAP2K6 | 0.48794359 |
| 87 | PDPK1 | 0.47965711 |
| 88 | MET | 0.44917562 |
| 89 | FER | 0.41422546 |
| 90 | RPS6KA6 | 0.40385438 |
| 91 | BMPR1B | 0.40343957 |
| 92 | PTK6 | 0.39200305 |
| 93 | PRKAA2 | 0.38699361 |
| 94 | ABL2 | 0.37611799 |
| 95 | STK10 | 0.37190074 |
| 96 | MAPK11 | 0.37157038 |
| 97 | PAK4 | 0.35868807 |
| 98 | LATS1 | 0.35221562 |
| 99 | TRIB3 | 0.35126709 |
| 100 | FGFR2 | 0.34921021 |
| 101 | CDK3 | 0.33562645 |
| 102 | PDK1 | 0.33328183 |
| 103 | MAPK15 | 0.33274545 |
| 104 | MAP3K2 | 0.32923509 |
| 105 | PAK3 | 0.32679882 |
| 106 | NUAK1 | 0.32494047 |
| 107 | ADRBK2 | 0.32239234 |
| 108 | PRKCI | 0.32115287 |
| 109 | MAP3K14 | 0.32048517 |
| 110 | KSR2 | 0.31893488 |
| 111 | RPS6KC1 | 0.31231086 |
| 112 | RPS6KL1 | 0.31231086 |
| 113 | PRKD2 | 0.30464690 |
| 114 | ADRBK1 | 0.27789473 |
| 115 | PRKCZ | 0.26965525 |
| 116 | YES1 | 0.26880033 |
| 117 | JAK2 | 0.24262187 |
| 118 | STK11 | 0.23144887 |
| 119 | PRKCD | 0.22714174 |
| 120 | NEK9 | 0.21909037 |
| 121 | IRAK2 | 0.21853214 |
| 122 | NTRK1 | 0.20897128 |
| 123 | PRKACG | 0.20868671 |
| 124 | FRK | 0.20144891 |
| 125 | PTK2B | 0.19925990 |
| 126 | RIPK1 | 0.16684039 |
| 127 | MAPK12 | 0.16351891 |
| 128 | PRKCH | 0.15293689 |
| 129 | EPHA4 | 0.15175601 |
| 130 | IRAK1 | 0.14766149 |
| 131 | PRKCA | 0.14106017 |
| 132 | AKT2 | 0.13195396 |
| 133 | ERBB4 | 0.11768596 |
| 134 | PIM1 | 0.11205776 |
| 135 | PRKACA | 0.11143698 |
| 136 | MAP2K2 | 0.08948354 |
| 137 | MAP3K13 | 0.06843773 |
| 138 | MYLK | 0.06430356 |
| 139 | TGFBR1 | 0.06415569 |
| 140 | MINK1 | 0.06232148 |
| 141 | INSR | 0.06021983 |
| 142 | MAP4K1 | 0.05611126 |
| 143 | IGF1R | 0.04860007 |
| 144 | BMX | 0.04390955 |
| 145 | MAP3K11 | 0.03921949 |
| 146 | IRAK3 | 0.03913600 |
| 147 | MAP2K3 | 0.03577333 |
| 148 | CSNK1A1 | 0.03262938 |
| 149 | CAMK4 | 0.03121777 |
| 150 | NME2 | 0.02785657 |
| 151 | SRC | 0.02329826 |
| 152 | PRKD3 | 0.02078058 |
| 153 | PDGFRA | 0.01916291 |
| 154 | EPHB2 | 0.01892648 |
| 155 | PRKCQ | 0.01801705 |
| 156 | MATK | 0.01735991 |
| 157 | CSK | 0.01570543 |
| 158 | MTOR | 0.01012332 |
| 159 | ROCK1 | 0.00525045 |
| 160 | TYK2 | -0.0072892 |
| 161 | RPS6KA3 | -0.0043003 |
| 162 | MAP2K1 | -0.0015949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.45534412 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.92779650 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.60628051 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.53233578 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.52893296 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.50330678 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.44465296 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.23386128 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.22144580 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.17556704 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.14458335 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.00017053 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93662402 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70134385 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57892050 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.52006484 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.47410758 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.46196727 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.45275106 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44860715 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.39781903 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39703403 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34232158 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28930361 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.19708829 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14891500 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12647605 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.12050922 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.11466840 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10553859 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10474379 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.03030046 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95059467 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92435749 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.90454242 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.89369102 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.84982690 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84342484 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83787604 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80511773 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73408198 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.69884222 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68003459 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.63206611 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61134908 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58226921 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50700078 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49843594 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48986522 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48155807 |
| 51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47509551 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42678944 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.41675220 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40609819 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40380432 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 1.37903533 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37285547 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 1.34793377 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32083160 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31334162 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31327599 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29634728 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26131220 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24999144 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 1.24747746 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23384039 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21417493 |
| 68 | Malaria_Homo sapiens_hsa05144 | 1.20189369 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19308226 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 1.19043570 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11140482 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10417431 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10134704 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03810915 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03219109 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02837729 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01188853 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01170604 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00893223 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.98715458 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96930170 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96475756 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95844363 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88924485 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88850332 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88652233 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.86543043 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85839001 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82733200 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81723509 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81161670 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80575893 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80517348 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80051698 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77391297 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76847108 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.76777781 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76215027 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75446875 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73743120 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73134564 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72939954 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72736824 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71984130 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70419305 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69844572 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.69690466 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69426865 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69175691 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67721984 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67429381 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67153231 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64404161 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64375673 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63420675 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63018939 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.62642405 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61284833 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60963441 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60595134 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58566954 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57846682 |
| 123 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56494007 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54073923 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51221747 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51118573 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50391005 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48870694 |
| 129 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48572470 |
| 130 | Phagosome_Homo sapiens_hsa04145 | 0.47925562 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47820490 |
| 132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47597285 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46895086 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46555105 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45989081 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.45585774 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42291059 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41622465 |
| 139 | RNA polymerase_Homo sapiens_hsa03020 | 0.41413441 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41293057 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40824220 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39028777 |
| 143 | Shigellosis_Homo sapiens_hsa05131 | 0.36605757 |
| 144 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36601143 |
| 145 | Homologous recombination_Homo sapiens_hsa03440 | 0.34411665 |
| 146 | Parkinsons disease_Homo sapiens_hsa05012 | 0.33929030 |
| 147 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30718321 |
| 148 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29750530 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28674589 |
| 150 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28206985 |
| 151 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27328909 |
| 152 | Endocytosis_Homo sapiens_hsa04144 | 0.27274508 |
| 153 | Pertussis_Homo sapiens_hsa05133 | 0.26273328 |
| 154 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25598675 |
| 155 | ABC transporters_Homo sapiens_hsa02010 | 0.25531678 |
| 156 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25310770 |
| 157 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25166708 |
| 158 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23153639 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21515921 |
| 160 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.20208186 |
| 161 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19867980 |
| 162 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16419859 |
| 163 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15687204 |
| 164 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14860657 |
| 165 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12424965 |
| 166 | Insulin resistance_Homo sapiens_hsa04931 | 0.11691243 |
| 167 | Alzheimers disease_Homo sapiens_hsa05010 | 0.11041301 |
| 168 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10213924 |
| 169 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.08404987 |
| 170 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07680663 |
| 171 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.05028718 |
| 172 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.02737957 |
| 173 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02397201 |
| 174 | Bladder cancer_Homo sapiens_hsa05219 | 0.02229251 |
| 175 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.00618153 |
| 176 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0538141 |
| 177 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0378518 |
| 178 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0350240 |
| 179 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0150352 |
| 180 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0131710 |
| 181 | Hepatitis C_Homo sapiens_hsa05160 | -0.0045033 |

